HFM Investment Advisors’s Avidity Biosciences RNAM Stock Holding History

HFM Investment Advisors’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$73	–	1285
2025 Q4	$73	Hold	1	–	–	﹤0.01%	1199
2025 Q3	$44	Buy	+1	New	+$40	﹤0.01%	1227

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

HFM Investment Advisors's RNAM Position: Q1 2026 in Review

HFM Investment Advisors sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 1 share — an estimated $73 sold.

HFM Investment Advisors first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $73 in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

HFM Investment Advisors reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
HFM Investment Advisors sold 1 Avidity Biosciences share in Q1 2026, an estimated $73.
HFM Investment Advisors first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
HFM Investment Advisors's Avidity Biosciences position peaked at $73 in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on HFM Investment Advisors's 13F filing for Q1 2026, filed 1 May 2026.